In addition to PD-L1 staining, tumor-infiltrating immune cells were identified by IHC as CD3+ tumor infiltrating lymphocytes (TIL) and CD68+ tumor infiltrating myeloid cells (TIM). This evidence concerns the gene CD274 and neoplasm.